CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients.

Yu LuYizhou HuangLei HuangYanjie XuZien WangHan LiTing ZhangMing ZhongWei-Qiang GaoYan Zhang

Published in: BMC immunology (2020)

Our findings indicated that CD16 expression on neutrophils in peripheral blood was a good prognostic marker for predicting efficacy of capecitabine in CRC patients.

Keyphrases

poor prognosis
peripheral blood
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
phase ii study
peritoneal dialysis
prognostic factors
binding protein
squamous cell carcinoma
phase iii
patient reported outcomes
nk cells
patient reported